You are here:


Name SMC ID No Status Sub. Type
alendronate colecalciferol (Fosavance) 213/05 Superseded Abbreviated Submission
aprepitant (Emend) 242/06 Not Recommended Full submission
aprepitant (Emend) 242/06 Not Recommended Resubmission
aprepitant (Emend) 1241/17 Accepted Full submission
aprepitant (Emend) 1252/17 Accepted Abbreviated Submission
aprepitant (Emend) 132/04 Restricted Full submission
bezlotoxumab (Zinplava) 1293/17 Not Recommended Non submission
boceprevir (Victrelis) Experienced Patients 722/11 Accepted Full submission
boceprevir (Victrelis) Naive Patients 723/11 Accepted Full submission
caspofungin (Cancidas) 147/04 Restricted Full submission
caspofungin (Cancidas) 551/09 Accepted Abbreviated Submission
caspofungin (Cancidas) 552/09 Restricted Abbreviated Submission
caspofungin acetate (Caspofungin) 74/03 Restricted Full submission
caspofungin acetate (Caspofungin) 30/03 Not Recommended Full submission
ceftolozane-tazobactam (Zerbaxa) 1146/16 Not Recommended Full submission
corifollitropin alfa (Elonva) 633/10 Not Recommended Non submission
daptomycin (Cubicin) 1309/18 Not Recommended Non submission
dorzolamide (Trusopt) 238/06 Restricted Abbreviated Submission
dorzolomide (Cosopt) 293/06 Restricted Abbreviated Submission
elbasvir-grazoprevir (Zepatier) 1203/17 Accepted Full submission
ertapenem (Invanz) 134/04 Restricted Full submission
ertapenem (Invanz) 404/07 Restricted Full submission
ertapenem 1g vial of powder for solution for intravenous infusion (Invanz) 335/06 Restricted Full submission
ertapenem sodium infusion (Invanz) Paediatric 291/06 Restricted Abbreviated Submission
etonogestrel (Nexplanon) 655/10 Accepted Abbreviated Submission
etoricoxib (Arcoxia) 576/09 Not Recommended Non submission
etoricoxib (Arcoxia) 847/12 Not Recommended Non submission
etoricoxib (Arcoxia) 31/03 Accepted Full submission
etoricoxib 60mg, 90mg and 120mg tablets (Arcoxia) 313/06 Accepted Abbreviated Submission
ezetimibe (Ezetrol) 61/03 Restricted Full submission
ezetimibe/simvastatin (Inegy) 182/05 Restricted Abbreviated Submission
fosaprepitant (Ivemend) 506/08 Withdrawn Full submission
fosaprepitant dimeglumine (IVEmend 150mg) 678/11 Accepted Abbreviated Submission
golimumab (Simponi) 674/11 Not Recommended Full submission
golimumab (Simponi) 674/11 Accepted Resubmission
golimumab (Simponi) 733/11 Superseded Full submission
golimumab (Simponi) 1124/16 Accepted Full submission
golimumab (Simponi) 946/13 Not Recommended Non submission
golimumab (Simponi) 946/13 Superseded Full submission
golimumab (Simponi) (AS) 721/11 Superseded Full submission
golimumab (Simponi®) 1199/16 Not Recommended Non submission
infliximab (Remicade) 374/07 Superseded Resubmission
infliximab (Remicade) 739/11 Not Recommended Non submission
infliximab (Remicade) 854/13 Superseded Full submission
insulin lispro (Humalog KwikPen) 508/08 Accepted Abbreviated Submission
insulin lispro (Humalog Mix25, Mix50 KwikPen) 509/08 Accepted Abbreviated Submission
losartan (Cozaar) 131/04 Restricted Full submission
losartan (Cozaar) 112/04 Accepted Full submission
losartan (Cozaar) 295/06 Accepted Abbreviated Submission
losartan hydrochlorothiazide (Cozaar) 296/06 Accepted Abbreviated Submission
montelukast (Singulair paediatric) 383/07 Restricted Full submission
montelukast (Singulair) 185/05 Restricted Full submission
montelukast (Singulair) 111/04 Accepted Abbreviated Submission
nicotinic acid/laropiprant (Tredaptive) 614/10 Suspended Full submission
nomegestrol acetate / estradiol (Zoely) 898/13 Not Recommended Non submission
oestrogens, conjugated, bazedoxifene acetate (Duavive) 1220/17 Not Recommended Non submission
pegylated interferon alfa-2b (Viraferon Peg) 794/12 Superseded Abbreviated Submission
pembrolizumab (Keytruda) 1204/17 Restricted Full submission
pembrolizumab (Keytruda) 1086/15 Accepted Full submission
pembrolizumab (Keytruda) 1087/15 Not Recommended Resubmission
pembrolizumab (Keytruda) 1239/17 Restricted Full submission
pembrolizumab (Keytruda) 1087/15 Not Recommended Full submission
pembrolizumab (Keytruda) UC 1291/18 Restricted Full submission
posaconazole (Noxafil) 999/14 Restricted Abbreviated Submission
posaconazole (Noxafil) 1067/15 Accepted Abbreviated Submission
raltegravir (Isentress) 613/10 Restricted Full submission
raltegravir (Isentress) 1102/15 Restricted Abbreviated Submission
raltegravir (Isentress) 1113/15 Restricted Abbreviated Submission
raltegravir (Isentress) 902/13 Restricted Abbreviated Submission
raltegravir (Isentress) 461/08 Restricted Full submission
raltegravir (Isentress) 1280/17 Restricted Abbreviated Submission
sitagliptin (Januvia) 505/08 Accepted Full submission
sitagliptin (Januvia) 1083/15 Accepted Full submission
sitagliptin (Januvia) 408/07 Restricted Full submission
sitagliptin (Januvia) monotherapy 607/10 Restricted Full submission
sitagliptin plus metformin (Janumet 50/1000) 627/10 Accepted Abbreviated Submission
sitagliptin/metformin (Janumet) 492/08 Restricted Abbreviated Submission
sugammadex (Bridion) 527/09 Restricted Full submission
sugammadex (Bridion) 527/09 Restricted Resubmission
tafluprost (Saflutan) 581/09 Restricted Full submission